Evidence map›Paper›PMID 42169773›Full record

ArticleGlobal translational medicine2025

CoreView imaging on needle: Rapid core-needle biopsy imaging for point-of-care breast cancer diagnosis.

Jocelyn R Jensen, Duy Do, Yuan-Ping Chang, Sophia Anderson, Matthew D Carson, Suzanne Dintzis, Richard M Levenson, Eric J Seibel

Abstract read
In one paragraph

Article in Global translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jocelyn R JensenDepartment of Bioengineering, College of Engineering and UW Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0009-0009-8137-981X
Duy DoHuman Photonics Laboratory, College of Engineering, University of Washington, Seattle, Washington, United States of America.ORCID 0009-0002-9218-9826
Yuan-Ping ChangHuman Photonics Laboratory, College of Engineering, University of Washington, Seattle, Washington, United States of America.ORCID 0009-0004-0792-9979
Sophia AndersonHuman Photonics Laboratory, College of Engineering, University of Washington, Seattle, Washington, United States of America.ORCID 0009-0004-7909-2493
Matthew D CarsonHuman Photonics Laboratory, College of Engineering, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-3831-3788
Suzanne DintzisDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-9762-030X
Richard M LevensonDepartment of Pathology and Laboratory Medicine, UC Davis Health, University of California, Davis, California, United States of America.ORCID 0000-0002-0112-6823
Eric J SeibelDepartment of Bioengineering, College of Engineering and UW Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-3382-6541

Funding

Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in GhanaU01CA269191 · NCI · UNIVERSITY OF WASHINGTON · PI RICHARD M. LEVENSON, Eric J Seibel · 2023 to 2026
$2.4M
IMAT-ITCR Collaboration: Combining FIBI and topological data analysis: Synergistic approaches for tumor structural microenvironment explorationR33CA278544 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ICZKOWSKI, KENNETH A · 2023 to 2025
$988k
Rapid Needle Biopsy Assessment at Point of Care to advance personalized cancer therapyR21CA246359 · NCI · UNIVERSITY OF WASHINGTON · PI SEIBEL, ERIC J · 2020 to 2021
$582k
NCI NIH HHS R21 CA246359NCI NIH HHS R33 CA278544NCI NIH HHS U01 CA269191
6 · The paper itself

Abstract

Breast cancer (BC) is one of the most prevalent malignancies worldwide, with early and rapid diagnosis playing a critical role in improving patient outcomes. Core-needle biopsies (CNBs) are the current gold standard for minimally invasive BC diagnoses. However, in low-resource and rural settings, access to CNB diagnostics is limited by infrastructural constraints, long histopathology turnaround times, as well as financial and geographical barriers. To address these challenges, we developed the CoreView imaging on needle (ION), an affordable, integrated imaging system designed to provide rapid, and point-of-care diagnostic assessment of CNB samples. The CoreView ION integrates microscopy with ultraviolet surface excitation technology, enabling the imaging of tissue biopsy surfaces within 5 min, significantly reducing diagnostic delays. This study presents the design, fabrication, and verification of the CoreView ION prototype operation, including its imaging workflow, staining protocols, and tissue compression testing. Our results demonstrate that the system can successfully generate histology-grade images of porcine and murine fresh biopsies, preserving cellular and nuclear detail of normal and tumor tissue. By streamlining CNB imaging and incorporating mainly manual low-cost components, the CoreView ION has the potential to improve BC diagnostics in low-resource settings, ultimately enhancing early detection and patient care.

Indexed as

Breast cancerDiagnosticsGlobal healthMicroscopy with ultraviolet surface excitation imagingPoint-of-care

Identifiers

PMID42169773
PMCPMC13189065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.